We demonstrated that, in distinction to classical opioid receptors, ACKR3 will not trigger classical G protein signaling and is not modulated with the classical prescription or analgesic opioids, including morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists such as naloxone. Rather, we recognized that LIH383, an ACKR3-selective subnanomolar https://jacku926nrq1.bloginder.com/profile